524372:BOM
Orchid Pharma Ltd
₹908.75
arrow_downward
-1.88%(-17.40) 1D
Okt 16, 9:58:14 AM GMT+5:30 · INR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa 524372...
Buksan
₹928.40
Mataas
₹940.65
Mababa
₹905.50
Mkt. cap
54.26B
Avg. na dami
6.82K
Dami
1.36K
Mataas nang 52-wk
₹1,142.65
Mababa nang 52-wk
₹471.30
Bilang ng mga empleyado
1K
Buksan
₹928.40
Mataas
₹940.65
Mababa
₹905.50
Mkt. cap
54.26B
Avg. na dami
6.82K
Dami
1.36K
Mataas nang 52-wk
₹1,142.65
Mababa nang 52-wk
₹471.30
Bilang ng mga empleyado
1K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Reuters
·
1 buwan ang nakalipas
S&P 500 to end 2026 slightly above current levels on profit optimism
Bloomberg.com
·
1 linggo ang nakalipas
Oil Rise Spurs Fresh Selling in Stocks and Bonds: Markets Wrap
CNBC
·
1 buwan ang nakalipas
Equal-weight S&P 500 is leading the 2026 market and its flagship trade just hit $100 billion
marketscreener.com
·
17 minuto ang nakalipas
Epiroc trades today on Nasdaq Stockholm ex-dividend by 1.90 kronor per share
Profile
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai. It was founded by Kailasam Raghavendra Rao on 1 July 1992. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
Tungkol sa Orchid Pharma Ltd